Searchable abstracts of presentations at key conferences in endocrinology

ea0084op-05-25 | Oral Session 5: Autoimmunity | ETA2022

Intestinal barrier permeability in patients with hashimoto’s thyroiditis associated to non-endocrine autoimmune disorders

Virili Camilla , Stramazzo Ilaria , Capriello Silvia , Brusca Nunzia , Flavia Bagaglini Maria , Nocella Cristina , Carnevale Roberto , Centanni Marco

Objective: Intestinal barrier (IB) is one of the wider human body surface, whose integrity allows the uptake of nutrients also preserving from the entrance of harmful compounds. An increased permeability of IB, known as “leaky gut”, has been demonstrated in patients with intestinal inflammatory and/or autoimmune disorders as well as in patients with autoimmune diseases involving organs far from the intestine, as in patients with Hashimoto’s thyroiditis (HT). The...

ea0084op-11-53 | Oral Session 11: Young Investigators / Basic | ETA2022

CD3+CD8+CD20+ T cells as a marker of the inflammatory phase in thyroid autoimmune and related polyautoimmune disorders: a pilot study

Stramazzo Ilaria , Virili Camilla , Capriello Silvia , Brusca Nunzia , Flavia Bagaglini Maria , Romeo Giovanna , Mangino Giorgio , Centanni Marco

Objectives: Human CD3+CD20+ T cells represents 3-5% of circulating T cells and may be detected in all lymphatic organs and in the cerebrospinal fluid. In healthy individuals CD3+CD20+ T cells have been shown to produce higher levels of IL-17A and/or IFN-γ than those of CD3+CD20- T cells. Some reports described the role of CD3+CD20+ T cells in autoimmune disorders such as multiple scler...

ea0092op-11-02 | Oral Session 11: Autoimmunity / Hyperthyroidism | ETA2023

Systematic assessment of polyautoimmunity in patients with established lymphocytic thyroiditis

Centanni Marco , Stramazzo Ilaria , Capriello Silvia , Flavia Bagaglini Maria , Giulia Santaguida Maria , Gargano Lucilla , Brusca Nunzia , Virili Camilla

Background: The association of autoimmune thyroiditis (AIT) with nonendocrine autoimmune disorders has been reputed for long time as a variant of type 2 polyglandular autoimmune syndrome (PAS2). Nowadays, it is framed in the picture of polyautoimmunity and its relevance is owed to its prevalence, far higher than PAS 2, and its expanding galaxy. Systematic studies on this field are rather scanty and mostly based only on the presence of circulating antibodies. Our study has been...